Serum Metabolic Fingerprinting to Detect Human Nasopharyngeal Carcinoma Based on Gas Chromatography-Mass Spectrometry and Partial Least Squares-Linear Discriminant Analysis

REFERENCES

• Arani'bar , N. , K.-H. Ott , V. Roongta , and L. Mueller . 2006 . Metabolomic analysis using optimized NMR and statistical methods . Anal. Biochem. 355 ( 1 ): 62 – 70 .
   Google Scholar
• Brennan , B. 2006 . Nasopharyngeal carcinoma . Orphanet J. Rare Dis. 1 : 23 – 27 .
   PubMed Web of Science ®Google Scholar
• Chan , K. H. , Y. L. Gu , F. Ng , P. S. Ng , W. H. Seto , J. S. Sham , et al. . 2003 . EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma . Int. J. Cancer 105 ( 5 ): 706 – 709 .
   Google Scholar
• Chang , J. T. , J. Y. Ko , and R. L. Hong . 2004 . Recent advances in the treatment of nasopharyngeal carcinoma . J. Formos. Med. Assoc. 103 : 496 – 510 .
   PubMed Web of Science ®Google Scholar
• Chen , Y. K. , C. T. Su , H. J. Ding , K. H. Chi , J. A. Liang , Y. Y. Shen , L. K. Chen , C. L. Yeh , A. C. Liao , and C. H. Kao . 2006 . Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients . Anticancer Res. 26 : 1471 – 1477 .
   PubMedGoogle Scholar
• Cheng , A.-L. , W.-G. Huang , Z.-C. Chen , F. Peng , P.-F. Zhang , M.-Y. Li , et al. . 2008 . Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis . Clin. Cancer Res. 14 ( 2 ): 435 – 445 .
   Google Scholar
• Cho , W. C. 2007 . Nasopharyngeal carcinoma: Molecular biomarker discovery and progress . Mol. Cancer 6 : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• Dai , X. D. , L. D. Li , F. Z. Lu , S. W. Zhang , J. Sun , Y. J. Lin , X. W. Sun , and Y. P. Shi . 1999 . Trends and recent prediction in mortality of nasopharyngeal carcinoma during 20 years in China . J. Pract. Oncol. 13 : 1 – 5 .
   Google Scholar
• DeNittis , A. S. , L. Liu , D. I. Rosenthal , and M. Machtay . 2004. Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy, and concurrent/adjuvant chemotherapy. Am. J. Clin. Oncol. 25: 93–95.
   Google Scholar
• Fandi , A. , M. Altunm , N. Azli , J. P. Armand , and E. Cvitkovic . 1994 . Nasopharyngeal cancer: Epidemiology, staging, and treatment . Semin. Oncol. 21 ( 3 ): 382 – 397 .
   Google Scholar
• Fiehn , O. 2002 . Metabolomics- the link between genotype and phenotype . Plant Mol. Biol. 48 : 155 – 171 .
   PubMed Web of Science ®Google Scholar
• Frickenschmidt , A. , H. Frohlich , D. Bullinger , A. Zell , S. Laufer , C. H. Gleiter , H. Liebich , and B. Kammerer . 2008 . Metabonomics in cancer diagnosis: Mass spectrometry-based profiling of urinary nucleosides from breast cancer patients . Biomarkers 13 ( 4 ): 435 – 449 .
   PubMed Web of Science ®Google Scholar
• Griffin , J. L. 2003 . Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis . Curr. Opin. Chem. Biol. 7 ( 5 ): 648 – 654 .
   PubMed Web of Science ®Google Scholar
• Guo , X. , R. C. Johnson , H. Deng , J. Liao , L. Guan , G. W. Nelson , et al. 2009 . Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China . Int. J. Cancer 124 ( 12 ): 2942 – 2947 .
   Google Scholar
• Henle , G. , and W. Henle . 1976 . Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma . Int. J. Cancer 17 : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Hsiao , J. R. , Y. T. Jin , and S. T. Tsai . 2002 . Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma . Cancer 94 ( 3 ): 723 – 729 .
   PubMedGoogle Scholar
• Jeyakumar , A. , T. M. Brickman , A. Jeyakumar , and T. Doerr . 2006 . Review of nasopharyngeal carcinoma . Ear, Nose, Throat J. 85 ( 3 ): 168 – 170 , 172–173, 184 .
   PubMedGoogle Scholar
• Kim , K. , P. Aronov , S. O. Zakharkin , D. Anderson , B. Perroud , I. M. Thompson , and R. H. Weiss . 2009 . Urine metabolomics analysis for kidney cancer detection and biomarker discovery . Mol. Cell Proteomics 8 ( 3 ): 558 – 570 .
   PubMed Web of Science ®Google Scholar
• Krishna , S. M. , S. James , J. Kattoor , and P. Balaram . 2004 . Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin . Jap. J. Clin. Oncol. 34 ( 6 ): 307 – 311 .
   Google Scholar
• Leung , S. F. , Y. M. Lo , A. T. Chan , K. F. To , E. To , L. Y. Chan , B. Zee , D. P. Huang , and P. J. Johnson . 2003 . Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2 . Clin. Cancer Res. 9 ( 9 ): 3431 – 3434 .
   Google Scholar
• Li , L. D. , F. Z. Lu , S. W. Zhang , R. Mu , X. D. Sun , X. M. Huangpu , et al. 1997 . Trends and recent prediction in mortality of cancer during 20 years in China . Chin. J. Oncol. 19 : 3 – 9 .
   Google Scholar
• Liotta , L. A. , and E. C. Kohn . 2001 . The microenvironment of the tumour-host interface . Nature 411 : 375 – 379 .
   PubMed Web of Science ®Google Scholar
• Lo , Y. M. , L. Y. Chan , K. W. Lo , S. F. Leung , J. Zhang , A. T. Chan , J. C. Lee , N. M. Hjelm , P. J. Johnson , and D. P. Huang . 1999 . Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma . Cancer Res. 59 ( 6 ): 1188 – 1191 .
   PubMedGoogle Scholar
• Mackie , A. M. , J. B. Epstein , J. S. Wu , and P. Stevenson-Moore . 2000 . Nasopharyngeal carcinoma: The role of the dentist in assessment, early diagnosis and care before and after cancer therapy . Oral Oncol 36 ( 5 ): 397 – 403 .
   Google Scholar
• Odunsi , K. , R. M. Wollman , C. B. Ambrosone , A. Hutson , S. E. McCann , J. Tammela , et al. 2005 . Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics . Int. J. Cancer 113 : 782 – 788 .
   PubMed Web of Science ®Google Scholar
• Pongsuwan , W. , E. Fukusaki , T. Bamba , T. Yonetani , T. Yamahara , and A. Kobayashi . 2007 . Quality prediction of Japanese green tea using pyrolyzer coupled GC/MS based metabolic fingerprinting . J. Agric. Food Chem. 55 : 231 – 236 .
   PubMed Web of Science ®Google Scholar
• Raab-Traub , N. 2002 . Epstein-Barr virus in the pathogenesis of NPC . Semin. Cancer Biol. 12 : 431 – 441 .
   PubMed Web of Science ®Google Scholar
• Rudell , D. R. , J. P. Mattheis , and E. A. Curry . 2008. Prestorage ultraviolet-white light irradiation alters apple peel metabolome. J. Agric. Food Chem. 56: 1138–1147.
   PubMed Web of Science ®Google Scholar
• Samuelsson , L. M. , L. Forlin , G. Karlsson , M. Adolfsson-Erici , and D. G. J. Larsson . 2006 . Using NMR metabolomics to identify responses of an environmental estrogen in blood plasma of fish . Aquatic Toxicol. 78 ( 4 ): 341 – 349 .
   PubMed Web of Science ®Google Scholar
• Schauer , N. , D. Steinhauser , S. Strelkov , D. Schomburg , G. Allison , T. Moritz , et al. 2005 . GC-MS libraries for the rapid identification of metabolites in complex biological samples . FEBS Lett. 579 ( 6 ): 1332 – 1337 .
   PubMed Web of Science ®Google Scholar
• Shepherd , T. , G. Dobson , S. R. Verrall , S. Conner , D. W. Griffiths , J. W. McNicol , H. V. Davies , and D. Stewart . 2007 . Potato metabolomics by GC–MS: What are the limiting factors? Metabolomics 3 : 475 – 488 .
   Web of Science ®Google Scholar
• Sreekumar , A. , L. M. Poisson , T. M. Rajendiran , A. P. Khan , Q. Cao , J. Yu , et al. . 2009 . Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression . Nature 457 ( 7231 ): 910 – 914 .
   PubMed Web of Science ®Google Scholar
• Styczynski , M. P. , J. F. Moxley , L. V. Tong , J. L. Walther , K. L. Jensen , and G. N. Stephanopoulos . 2007 . Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery . Anal. Chem. 79 : 966 – 973 .
   PubMed Web of Science ®Google Scholar
• Tiziani , S. , V. Lopes , and U. L. Günther . 2009 . Early stage diagnosis of oral cancer using 1H NMR-based metabolomics . Neoplasia 11 ( 3 ): 269 – 276 .
   PubMed Web of Science ®Google Scholar
• Wong , T.-S. , D. L.-W. Kwong , J. S.-T. Sham , W. I. Wei , Y.-L. Kwong , and A. P.-W. Yuen . 2004 . Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma . Clin. Cancer Res. 10 ( 7 ): 2401 – 2406 .
   PubMed Web of Science ®Google Scholar
• Yi , L. Z. , J. He , Y. Z. Liang , D. L. Yuan , and F. T. Chau . 2006 . Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA . FEBS Lett. 580 : 6837 – 6845 .
   PubMed Web of Science ®Google Scholar
• Yi , L. Z. , D. L. Yuan , Z. Hong Che , Y. Z. Liang , Z. G. Zhou , H. Y. Gao , and Y. M. Wang . 2008 . Plasma fatty acid metabolic profile coupled with uncorrelated linear discriminant analysis to diagnose and biomarker screening of type 2 diabetes and type 2 diabetic coronary heart diseases . Metabolomics 4 : 30 – 38 .
   Web of Science ®Google Scholar
• Yu , M. C. , and J. M. Yuan . 2002 . Epidemiology of nasopharyngeal carcinoma . Sem. Canc. Biol. 12 : 421 – 429 .
   PubMed Web of Science ®Google Scholar
• Yuan , D. L. , Y. Z. Liang , L. Z. Yi , Q. S. Su , and O. M. Kvalheim . 2008 . Uncorrelated linear discriminant analysis (ULDA): A powerful tool for exploration of metabolomics data . Chemom. Intell. Lab. Syst. 93 : 70 – 79 .
   Google Scholar
• Lun Zhao Yi and Dan Juan Li contributed equally to this work.
   Google Scholar